Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07LZH
|
||||
Former ID |
DIB016958
|
||||
Drug Name |
ERB-041
|
||||
Synonyms |
2-(3-Fluoro-4-hydroxyphenyl)-7-vinylbenzoxazol-5-ol
|
||||
Drug Type |
Small molecular drug
|
||||
Structure |
Download2D MOL |
||||
Formula |
C15H10FNO3
|
||||
InChI |
InChI=1S/C15H10FNO3/c1-2-8-5-10(18)7-12-14(8)20-15(17-12)9-3-4-13(19)11(16)6-9/h2-7,18-19H,1H2
|
||||
InChIKey |
MQIMZDXIAHJKQP-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 524684-52-4
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Estrogen receptor beta | Target Info | Agonist | [532547], [551871] | |
KEGG Pathway | Estrogen signaling pathway | ||||
Prolactin signaling pathway | |||||
References | |||||
Ref 521827 | ClinicalTrials.gov (NCT00318500) Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women. U.S. National Institutes of Health. | ||||
Ref 541807 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6700). | ||||
Ref 532547 | Erb-041, an estrogen receptor-beta agonist, inhibits skin photocarcinogenesis in SKH-1 hairless mice by downregulating the WNT signaling pathway. Cancer Prev Res (Phila). 2014 Feb;7(2):186-98. | ||||
Ref 551871 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.